Pomerantz LLP is investigating claims on behalf of investors of Bruker Corporation ("Bruker" or the "Company") (NASDAQ: BRKR). Such investors are advised to contact Robert S. Willoughby at firstname.lastname@example.org or 888-476-6529, ext. 9980.
The investigation concerns whether Bruker and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On November 9, 2017, post-market, Bruker advised investors that on October 19, 2017, the Company received a notice of investigation and subpoena to produce documents from the U.S. Securities and Exchange Commission's ("SEC") Division of Enforcement. The SEC subpoena seeks information related to an employee terminated as part of a restructuring and matters involving Company policies, accounting practices related to revenue recognition and restructuring activities, as well as related financial reporting, disclosure, and compliance matters since January 2013. The subpoena also seeks information on previously identified material weakness in internal controls over accounting for income taxes, related financial reporting matters and certain payments for non-employee travel expenses.
On this news, Bruker's share price has fallen during intraday trading on November 10, 2017.
On this news, Bruker's share price fell $0.58 or 1.79%, to close at $31.75 on November 10, 2017.